Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Other financing activities: 2013-2020

Historic Other financing activities for Agios Pharmaceuticals (AGIO) over the last 7 years, with Dec 2020 value amounting to $250.5 million.

  • Agios Pharmaceuticals' Other financing activities was N/A to $250.5 million in Q2 2020 from the same period last year, while for Jun 2020 it was $250.2 million, marking a year-over-year change of. This contributed to the annual value of $250.5 million for FY2020, which is N/A change from last year.
  • Per Agios Pharmaceuticals' latest filing, its Other financing activities stood at $250.5 million for FY2020, which was up 63,975.96% from $391,000 recorded in FY2018.
  • In the past 5 years, Agios Pharmaceuticals' Other financing activities ranged from a high of $250.5 million in FY2020 and a low of -$638,000 during FY2017.
  • Its 2-year average for Other financing activities is $125.5 million, with a median of $125.5 million in 2018.
  • In the last 5 years, Agios Pharmaceuticals' Other financing activities plummeted by 377.39% in 2017 and then skyrocketed by 161.29% in 2018.
  • Over the past 4 years, Agios Pharmaceuticals' Other financing activities (Yearly) stood at $230,000 in 2016, then plummeted by 377.39% to -$638,000 in 2017, then surged by 161.29% to $391,000 in 2018, then reached $250.5 million in 2020.